The cancer-associated Sm-like (CaSm) oncogene is overexpressed in 87% of human pancreatic tumor samples and CaSm knockdown has demonstrated therapeutic efficacy in murine models of pancreatic cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback